Systematic review and meta-analysis on placenta accreta spectrum disorders in twin pregnancies: risk factors, detection rate and histopathology
- PMID: 34328297
- DOI: 10.23736/S2724-606X.21.04886-7
Systematic review and meta-analysis on placenta accreta spectrum disorders in twin pregnancies: risk factors, detection rate and histopathology
Abstract
Introduction: The occurrence of PAS has been recently associated with the presence of twin pregnancy. Aim of this review is to report the risk factors, histopathological correlation, diagnostic accuracy of prenatal ultrasound and clinical outcome of twin pregnancies complicated by placenta accreta spectrum (PAS) disorders.
Evidence acquisition: PubMed, Embase, Cinahl, Clinical Trial.Gov and Google Scholar databases were searched. Inclusion criteria were studies on twin pregnancies complicated by PAS. The outcomes explored were risk factors for PAS (including placenta previa, prior uterine surgery or assisted reproductive technology, ART), histopathology (placenta accreta and increta/percreta), detection rate of prenatal ultrasound and clinical outcome, including need for blood transfusion, hysterectomy, emergency or scheduled Cesarean delivery (CD), and maternal death. Random effect meta-analyses of proportions were sued to combine the data.
Evidence synthesis: Two studies considering 103 pregnancies were included in this systematic review: 41.86% (95% CI 27.0-57.9) of twin pregnancies complicated by PAS disorders had a prior CD, 28.22% (95% CI 13.4-46.0) presented placenta previa and 58.14% (95% CI 42.1-73.0) of twin pregnancies were conceived by ART. 74.49% (95% CI 41.6-96.5) of PAS in twin pregnancies were placenta accreta, while 25.51% (95% CI 3.5-58.4) were placenta increta or percreta. Prenatal diagnosis of PAS in twin pregnancies was accomplished only in 27.91% (95% CI 15.3-43.7) of cases. Finally, only one study consistently reported the clinical outcome of PAS in twins. 31.67% (95% CI 20.3-45.0) of women required blood transfusion, 26.67% (95% CI 16.1-39.7) had hysterectomy, while there was no case of maternal death. 44.19% of women had an emergency CD.
Conclusions: There is still limited evidence on the clinical course of PAS disorders in twin pregnancies. Placenta previa, prior uterine surgery (mainly CD), and ART are the most commonly risk factors for PAS disorders in twins. Prenatal diagnosis of PAS in twins is lower compared to what reported in singleton. Finally, about 30% of women with a twin pregnancy complicated by PAS required blood transfusion and hysterectomy.
Similar articles
-
Risk factors, prenatal diagnosis, and outcome of posterior placenta accreta spectrum disorders in patients with placenta previa or low-lying placenta: A multicenter study.Acta Obstet Gynecol Scand. 2025 Jul;104(7):1328-1338. doi: 10.1111/aogs.15132. Epub 2025 May 19. Acta Obstet Gynecol Scand. 2025. PMID: 40387324 Free PMC article.
-
Determinants of emergency Cesarean delivery in pregnancies complicated by placenta previa with or without placenta accreta spectrum disorder: analysis of ADoPAD cohort.Ultrasound Obstet Gynecol. 2024 Feb;63(2):243-250. doi: 10.1002/uog.27465. Ultrasound Obstet Gynecol. 2024. PMID: 37698306
-
Risk factors, histopathology and diagnostic accuracy in posterior placenta accreta spectrum disorders: systematic review and meta-analysis.Ultrasound Obstet Gynecol. 2021 Jun;57(6):903-909. doi: 10.1002/uog.22183. Ultrasound Obstet Gynecol. 2021. PMID: 32840934
-
Prospective evaluation of impact of post-Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder.Ultrasound Obstet Gynecol. 2022 Apr;59(4):474-482. doi: 10.1002/uog.23732. Epub 2022 Mar 8. Ultrasound Obstet Gynecol. 2022. PMID: 34225385 Free PMC article.
-
Emergency delivery in pregnancies at high probability of placenta accreta spectrum on prenatal imaging: a systematic review and meta-analysis.Am J Obstet Gynecol MFM. 2024 Oct;6(10):101432. doi: 10.1016/j.ajogmf.2024.101432. Epub 2024 Jul 26. Am J Obstet Gynecol MFM. 2024. PMID: 39069207
Cited by
-
The prenatal diagnostic indicators of placenta accreta spectrum disorders.Heliyon. 2023 May 17;9(5):e16241. doi: 10.1016/j.heliyon.2023.e16241. eCollection 2023 May. Heliyon. 2023. PMID: 37234657 Free PMC article. Review.
-
Screening of placenta accreta spectrum disorder using maternal serum biomarkers and clinical indicators: a case-control study.BMC Pregnancy Childbirth. 2023 Jul 11;23(1):508. doi: 10.1186/s12884-023-05784-2. BMC Pregnancy Childbirth. 2023. PMID: 37434137 Free PMC article.
-
Prevalence of fetal anomalies, stillbirth, neonatal morbidity, or mortality in pregnancies complicated by placenta accreta spectrum disorders.Acta Obstet Gynecol Scand. 2025 Apr;104 Suppl 1(Suppl 1):38-44. doi: 10.1111/aogs.14919. Epub 2024 Jul 14. Acta Obstet Gynecol Scand. 2025. PMID: 39004930 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources